Home › Funds › Nextech Invest Ltd. › RVMD
Nextech Invest Ltd. position in RVMD
REVOLUTION MEDICINES INC · Health Care
Nextech Invest Ltd. reported holding 7,601,087 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$1.42B, representing 67.55% of its reported portfolio and ranking #1 among its reported holdings. Nextech Invest Ltd. has disclosed RVMD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nextech Invest Ltd.'s RVMD position evolved
Nextech Invest Ltd. first disclosed a stake in RVMD in Q1 2025 at 7,601,087 shares (US$268.8M). The position peaked in Q2 2026 at 7,601,087 shares, worth US$1.42B. Across 6 filings, Nextech Invest Ltd. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 7,601,087 shares valued at US$1.42B.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 7.60M | $268.77M | New |
| Q2 2025 | 7.60M | $279.64M | Hold |
| Q3 2025 | 7.60M | $354.97M | Hold |
| Q4 2025 | 7.60M | $605.43M | Hold |
| Q1 2026 | 7.60M | $739.21M | Hold |
| Q2 2026 | 7.60M | $1.42B | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 60 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $1.19B · Q2 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.95M sh · $551.84M · Q2 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.30M sh · $430.18M · Q2 2026
- Nearwater Capital Markets, Ltd 2.10M sh · $392.73M · Q2 2026
More on Nextech Invest Ltd.
FAQ
How long has Nextech Invest Ltd. held RVMD?
Nextech Invest Ltd. has disclosed RVMD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Nextech Invest Ltd.'s current position in RVMD?
As of Q2 2026, Nextech Invest Ltd. holds 7.60M shares of RVMD (REVOLUTION MEDICINES INC), valued at $1.42B, representing 67.55% of its reported portfolio and ranking #1.
Has Nextech Invest Ltd. been buying or selling RVMD?
In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in RVMD. The position peaked in Q2 2026 at 7.60M shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.